OmicABEL statistics

You need an account to access this content

info

Citations per year

Citations chart
info

Popular tool citations

chevron_left Single SNP association chevron_right
Popular tools chart
info

Tool usage distribution map

Tool usage distribution map
info

Associated diseases

Associated diseases

OmicABEL specifications

Information


Unique identifier OMICS_24720
Name OmicABEL
Software type Package/Module
Interface Command line interface
Restrictions to use None
Operating system Unix/Linux
License GNU General Public License version 3.0
Computer skills Advanced
Stability Beta
Maintained Yes

Download


Versioning


Add your version

Documentation


Publication for OmicABEL

OmicABEL in publication

PMCID: 4916982
PMID: 27347381
DOI: 10.5256/f1000research.9397.r14057

[…] be used to look for variance heterogeneity in genetic studies. such heterogeneity is an indication of interaction between a genetic marker and either another marker or an unknown factor , ., in 2013 omicabel was added to the suite. it contains a high-performance computing based approach facilitating extremely fast mixed-model based regression of multiple omics traits like metabolomics […]

OmicABEL institution(s)
Aachen Institute for Advanced Study in Computational Engineering Science, Aachen, Germany; Institute of Cytology and Genetics, Siberian Division of the Russian Academy of Sciences, Novosibirsk, Russia; Novosibirsk State University, Novosibirsk, Russia; MRC Human Genetics Unit, Institute of Genetics and Molecular Medicine, University of Edinburgh, Edinburg, UK; Centre for Population Health Sciences, University of Edinburgh, Edinburgh, UK; Split University, Split, Croatia
OmicABEL funding source(s)
Supported by the Deutsche Forschungsgemeinschaft (German Research Association) through grant GSC 111, the Core grant from the Medical Research Council UK and a grant of the Ministry of Science, Education, and Sport of the Republic of Croatia (number 108-1080315-0302), the European Commission FP6 STRP grant number 018947 (LSHG-CT-2006-01947), a joint grant from RFBR and the Helmholtz society (Joint Research Groups, 12-04-91322), grant from the Russian Science Foundation (RSCF, grant no. 14-14-00313), and the European Union’s Seventh Framework Programme (FP7-Health) under the grant agreement no. 305280 (MIMOmics).

OmicABEL reviews

star_border star_border star_border star_border star_border
star star star star star

Be the first to review OmicABEL